                    . T                           212.


                .


        . to examine the alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia 1.


              1.                                   . T                       . T                                   . 1.1


              . T               .    21    2            T      21.


            . T              . T                  


THE ORIGINAL INTERNIST  21 T    


      . investigated dopamine reduction in the substantia nigra of PD patients using in vivo magnetic resonance spectroscopic imaging 21.2


T       


                  .        . T            1              . 1.


T     


                                               . 1.


T            T 


           212.


T  


   .                    21.


         .


T     


T                      . T                     . T                  21.


                      .                    .                . T                 . T   1     1        . T            12           .                 2. T                                   21. T                     .      .                              .  2          . T                           21.


       .  stablish whether increased oxidative damage in peripheral blood correlates with severity of PD  2.


               211


                                      .    


 


   2 2


 


       . to establish the effects of exercise induced oxidative stress on glutathione levels in Parkinson’s disease during off and on medication 21.


T   


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52